Oncology Information System Market worth $11.1 billion by 2027 - Leading Key Players are Koninklijke Philips N.V. (Netherlands), McKesson Corporation (US), Siemens Healthineers (Germany), Elekta AB (Sweden)

According to the new market research report "Oncology Information System Market by Product and Service, Application, End User (Hospitals & diagnostic imaging centers, Ablation & Cancer Care Centers, Government Institutions and Research Facilities) - Global Forecast to 2027", published by MarketsandMarkets™, the market is estimated to grow at a CAGR of 7.6% during the forecast period. The market is projected to reach USD 11.1 billion by 2027 from USD 7.7 billion in 2022.

Browse in-depth TOC on "Oncology Information System Market"
252 - Tables
61 - Figures
351 - Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1721676&utm_source=openpr&utm_medium=referral

The growth of this market is primarily driven by factors such as increasing need to curtail oncology care cost, growing adoption of electronic health records (EHR) and other oncology healthcare IT solutions to improve care quality, increasing incidence and prevalence of cancer, favorable government mandates and support for oncology information systems, potential benefits of and technological advancements in oncology information systems. Growing healthcare IT industry and integration of EMR with treatment planning systems indicates strong growth opportunities. On the other hand, the dearth of skilled IT professionals in the healthcare industry and interoperability issues are major factors expected to restrain the market growth. Concerns regarding data privacy is major market challenges.

Software to account for the largest share of the market during the forecast period

The oncology information system market for product and services is segmented into software and professional services. In 2021, the software segment accounted for 83.6% of the products and services market. The high share of this market segment can be attributed primarily to increasing need to control the growing oncology care costs and improve the efficiency of healthcare services by reducing medical errors.

Radiation Oncology to account for the largest share of the market during the forecast period

The radiation oncology segment accounted for the largest share of 53.8% of the oncology information systems market, by application, in 2021. Rising adoption of advanced radiology information systems during cancer diagnosis and therapeutics and technological advancements in radiological procedures are some of the factors responsible for the largest share of the segment.

Hospitals & diagnostic imaging centers to account for the largest share of the market during the forecast period

Based on end user, the global oncology information system market has been segmented into hospitals & diagnostic imaging centers, ablation & cancer care centers, government institutions, and research facilities. Hospitals & diagnostic imaging centers accounted for the largest share of 64.5% of the oncology information system market, by end user, in 2021. The largest share of this segment can be attributed to significant number of patient submissions/visits every year worldwide, increasing government initiatives aimed at equipping (or upgrading) hospitals with newer and advanced systems, increasing number of cancer care procedures, and the growing adoption of oncology treatment care.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1721676&utm_source=openpr&utm_medium=referral

The APAC Oncology information system market is projected to grow at the highest rate during the forecast period.

The oncology information system market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2021, North America accounted for 50.8% of the market during the forecast period. Increasing prevalence of cancers, large number of hospitals and the presence of major market players and the favorable government regulations for adoption of oncology information systems are some of the factors driving the demand for oncology information system in North America. The Asia Pacific region are expected to grow at higher CAGRs during the forecast period. The growth of the Asia Pacific oncology information system market is driven by increasing prevalence of cancer, increasing investment for advancement of healthcare IT infrastructure, and increasing government support for implementation of healthcare IT solutions in healthcare settings.

Key Market Players:

Prominent players in the oncology information system market are Koninklijke Philips N.V. (Netherlands), McKesson Corporation (US), Siemens Healthineers (Germany), Elekta AB (Sweden), Epic Systems Corporation (US), IBM (US), Cerner Corporation (US), Advanced Data Systems (US), Bogardus Medical Systems, Inc (US), F. Hoffmann-La Roche AG (Switzerland), Altai Oncology, LLC. (US), GE Healthcare (US), Accuray Incorporated (US), OPTUM (a part of UnitedHealth Group) (US), Allscripts Healthcare Solutions, Inc. (US), MICA Information Systems, Inc. (US), CureMD Healthcare (US), EndoSoft LLC (US), MIM Software Inc. (US) and RaySearch Laboratories AB (Sweden).

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=1721676&utm_source=openpr&utm_medium=referral

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.